Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000210·Sana Biotechnology, Inc.
Schedule 13G ownership disclosure
Sana Biotechnology Inc
Common Stock · CUSIP: 799566104
Event date: 2024-12-31
- Filing-level shares
- 10,747,760
- Percent of class
- 4.81%
- The Vanguard Group
Shares: 10,747,760 · Class: 4.81%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000210
- Form type
- SCHEDULE 13G/A
- Filer
- Sana Biotechnology, Inc.
- CIK
- CIK 1770121
- Filed
- Jan 31, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership